To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.
DRAVP ID DRAVPa2102
Peptide Name Sequence 3 from Patent US9880167B2
Sequence EVKLLEQSGAELVKPGASVRLSCTAS
Sequence Length 26
Source Synthetic peptide
Target Organism Dengue Virus
Patent Type Granted Patent
Publication Date 2018-01-30
Patent No US9880167B2
Family Info US9499607B2, CN104768574B, KR20200102524A, BR112015002605B1, ES2859574T3, CA2879994C, KR102165384B1, WO2014025546A2, EP2882453B1, AU2013299986B2, JP6297560B2, MX2019008736A, HK1210054A1, JP6605643B2,
Patent Title Anti-dengue virus antibodies and uses thereof
Comment
Abstract The present invention provides, among other things, antibody agents (e.g., antibodies, and/or antigen-binding fragments thereof) that bind to DV epitopes, as well as compositions containing them and methods of designing, providing, formulating, using, identifying and/or characterizing them. In some embodiments, provided antibody agents show significant binding to a plurality of DV serotypes. In some embodiments, provided antibody agents show significant binding to all four DV serotypes. Such antibody agents are useful, for example, in the prophylaxis, treatment, diagnosis, and/or study of DV.
To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.